HLA-G Transactivation by cAMP-response Element-binding Protein (CREB)

Sam J. P. Gobin, Paula J. Biesta, Jurriaan E.M. de Steenwinkel, Gert Datema, Peter J. van den Elsen

Journal of Biological Chemistry · 2002 · 66 citations · 26 references

DOIFull text

Open access

Concepts

Abstract

The expression of HLA-G in extravillous cytotrophoblast cells coincides with a general lack of classical major histocompatibility complex (MHC) class I expression in this tissue. This differential expression of HLA-G and classical HLA class I molecules in trophoblasts suggests a tight transcriptional control of MHC class I genes. Transactivation of the classical MHC class I genes is mediated by two groups of juxtaposed cis-acting elements that can be viewed as regulatory modules. Both modules are divergent in HLA-G, rendering this gene unresponsive to NF-κB, IRF1, and class II transactivator (CIITA)-mediated induction pathways. In this study, we searched for alternative regulatory elements in the 1438-bp HLA-G promoter region.HLA-G was not responsive to interferon-α (IFNα), IFNβ, or IFNγ, despite the presence of an upstream ISRE binding IRF1 in vitro. However, the HLA-G promoter contains three CRE/TRE elements with binding affinity for CREB/ATF and Fos/Jun proteins both in vitro and in vivo. In transient transfection assays, it was shown that HLA-Gtransactivation is regulated by CREB, CREB-binding protein (CBP), and p300. Moreover, immunohistochemical analysis demonstrated that HLA-G is co-expressed with CREB and CBP in extravillous cytotrophoblasts, revealing the in vivo relevance of this transactivation pathway. This implies a unique regulation of HLA-Gtranscription among the MHC class I genes. The expression of HLA-G in extravillous cytotrophoblast cells coincides with a general lack of classical major histocompatibility complex (MHC) class I expression in this tissue. This differential expression of HLA-G and classical HLA class I molecules in trophoblasts suggests a tight transcriptional control of MHC class I genes. Transactivation of the classical MHC class I genes is mediated by two groups of juxtaposed cis-acting elements that can be viewed as regulatory modules. Both modules are divergent in HLA-G, rendering this gene unresponsive to NF-κB, IRF1, and class II transactivator (CIITA)-mediated induction pathways. In this study, we searched for alternative regulatory elements in the 1438-bp HLA-G promoter region.HLA-G was not responsive to interferon-α (IFNα), IFNβ, or IFNγ, despite the presence of an upstream ISRE binding IRF1 in vitro. However, the HLA-G promoter contains three CRE/TRE elements with binding affinity for CREB/ATF and Fos/Jun proteins both in vitro and in vivo. In transient transfection assays, it was shown that HLA-Gtransactivation is regulated by CREB, CREB-binding protein (CBP), and p300. Moreover, immunohistochemical analysis demonstrated that HLA-G is co-expressed with CREB and CBP in extravillous cytotrophoblasts, revealing the in vivo relevance of this transactivation pathway. This implies a unique regulation of HLA-Gtranscription among the MHC class I genes. major histocompatibility complex antibody activation transcription factor class II transactivator CREB-binding protein CRE, cAMP-response element cAMP-response element-binding protein interferon γ-activated site inducible cAMP early repressor interferon interferon regulatory factor interferon-stimulated response element nuclear factor κB Rous sarcoma virus signal transducer and activator of transactivation 1 12-O-tetradecanoylphorbol-13-acetate TPA-response element The classical HLA class I molecules (HLA-A, HLA-B, and HLA-C) are highly polymorphic and are ubiquitously expressed on most somatic cells (reviewed in Ref. 1Le Bouteiller P. Crit. Rev. Immunol. 1994; 14: 89-129Crossref PubMed Google Scholar). They are essential in the immune response as they present antigen-derived peptides to cytotoxic T-lymphocytes and are important in protection against natural killer cell-mediated cytotoxicity. The nonclassical HLA class I molecules HLA-E, HLA-F, and HLA-G have a limited polymorphism and display a restricted expression pattern (reviewed in Refs. 1Le Bouteiller P. Crit. Rev. Immunol. 1994; 14: 89-129Crossref PubMed Google Scholar, 2Le Bouteiller P. Blaschitz A. Immunol. Rev. 1999; 167: 233-244Crossref PubMed Scopus (168) Google Scholar, 3Le Bouteiller P. Solier C. Microbes Infect. 2001; 3: 323-332Crossref PubMed Scopus (32) Google Scholar). Among the nonclassical HLA class I molecules, HLA-E and HLA-G have been shown to be able to present peptide (3Le Bouteiller P. Solier C. Microbes Infect. 2001; 3: 323-332Crossref PubMed Scopus (32) Google Scholar, 4O'Callaghan C.A. Bell J.I. Immunol. Rev. 1998; 163: 129-138Crossref PubMed Scopus (157) Google Scholar), whereas HLA-F is predominantly expressed as an empty intracellular molecule (5Wainwright S.D. Biro P.A. Holmes C.H. J. Immunol. 2000; 164: 319-328Crossref PubMed Scopus (93) Google Scholar). Although there is increasing evidence that nonclassical class I molecules could be important in protection against natural killer cell-mediated responses (2Le Bouteiller P. Blaschitz A. Immunol. Rev. 1999; 167: 233-244Crossref PubMed Scopus (168) Google Scholar, 3Le Bouteiller P. Solier C. Microbes Infect. 2001; 3: 323-332Crossref PubMed Scopus (32) Google Scholar), their exact role in T cell-mediated immune responses is still under debate. Additionally, HLA-G has been attributed alternative functional properties, such as interaction with and down-regulation of the function of CD4- and CD8-positive T cells (6Riteau B. Menier C. Khalil-Daher I. Sedlik C. Dausset J. Rouas-Freiss N. Carosella E.D. J. Reprod. Immunol. 1999; 43: 203-211Crossref PubMed Scopus (163) Google Scholar, 7Bainbridge D.R. Ellis S.A. Sargent I.L. J. Reprod. Immunol. 2000; 48: 17-26Crossref PubMed Scopus (232) Google Scholar, 8Fournel S. Aguerre-Girr M. Huc X. Lenfant F. Alam A. Toubert A. Bensussan A. Le Bouteiller P. J. Immunol. 2000; 15: 6100-6104Crossref Scopus (429) Google Scholar, 9Le Gal F.A. Riteau B. Sedlik C. Khalil-Daher I. Menier C. Dausset J. Guillet J.G. Carosella E.D. Rouas-Freiss N. Int. Immunol. 1999; 11: 1351-1356Crossref PubMed Scopus (279) Google Scholar, 10Lila N. Rouas-Freiss N. Dausset J. Carpentier A. Carosella E.D. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 12150-12155Crossref PubMed Scopus (291) Google Scholar). Among the MHC1 class I molecules, the expression of HLA-G is particularly restricted and is found in few tissues, including extravillous cytotrophoblast cells (3Le Bouteiller P. Solier C. Microbes Infect. 2001; 3: 323-332Crossref PubMed Scopus (32) Google Scholar, 11Carosella E.D. Dausset J. Kirszenbaum M. Immunol. Today. 1996; 17: 407-409Abstract Full Text PDF PubMed Scopus (113) Google Scholar). Coinciding with the expression of HLA-G in this tissue is a general lack of classical MHC class I expression (3Le Bouteiller P. Solier C. Microbes Infect. 2001; 3: 323-332Crossref PubMed Scopus (32) Google Scholar, 5Wainwright S.D. Biro P.A. Holmes C.H. J. Immunol. 2000; 164: 319-328Crossref PubMed Scopus (93) Google Scholar). Together, this is proposed to be of importance for materno-fetal tolerance (2Le Bouteiller P. Blaschitz A. Immunol. Rev. 1999; 167: 233-244Crossref PubMed Scopus (168) Google Scholar, 3Le Bouteiller P. Solier C. Microbes Infect. 2001; 3: 323-332Crossref PubMed Scopus (32) Google Scholar,11Carosella E.D. Dausset J. Kirszenbaum M. Immunol. Today. 1996; 17: 407-409Abstract Full Text PDF PubMed Scopus (113) Google Scholar, 12Loke Y.W. King A. Curr. Opin. Immunol. 1991; 3: 762-766Crossref PubMed Scopus (53) Google Scholar, 13Ober C. Am. J. Hum. Genet. 1998; 62: 1-5Abstract Full Text Full Text PDF PubMed Scopus (77) Google Scholar). The differential expression of HLA-G and classical HLA class I molecules in trophoblasts suggests a tight transcriptional control, which favors the expression of HLA-G and represses the expression of the classical class I genes HLA-A andHLA-B. Transcriptional control of classical MHC class I genes is mediated by conserved cis-acting regulatory elements in the proximal promoter region. These regulatory elements include enhancer A, the ISRE, and the SXY module (14Van den Elsen P.J. Gobin S.J. van Eggermond M.C. Peijnenburg A. Immunogenetics. 1998; 48: 208-221Crossref PubMed Scopus (123) Google Scholar). Enhancer A and the ISRE mediate the constitutive and cytokine-induced expression of MHC class I (15Gobin S.J.P. Keijsers V. Van Zutphen M. Van den Elsen P.J. J. Immunol. 1998; 161: 2276-2283PubMed Google Scholar, 16Gobin S.J.P. Van Zutphen M. Woltman A.M. Van den Elsen P.J. J. Immunol. 1999; 163: 1428-1434PubMed Google Scholar). The recently identified SXY module is important in the constitutive and CIITA-mediated transactivation (17Gobin S.J.P. Peijnenburg A. Van Eggermond M. Van Zutphen M. Van den Berg R. Van den Elsen P.J. Immunity. 1998; 9: 531-541Abstract Full Text Full Text PDF PubMed Scopus (100) Google Scholar). These classical regulatory elements are divergent in HLA-G, rendering this gene unresponsive to NF-κB-, IRF-1-, and CIITA-mediated induction pathways (18Gobin S.J.P. Van den Elsen P.J. Hum. Immunol. 2000; 61: 1102-1107Crossref PubMed Scopus (112) Google Scholar). In this study, we investigated the regulation of HLA-Gtransactivation and searched for alternative regulatory pathways. We assessed the capacity of putative regulatory elements in the promoter of HLA-G to bind transcription factors and to mediate transcriptional regulation of HLA-G. This search lead to the identification of three CRE/TRE elements, which bind proteins of the CREB/ATF and Fos/Jun families of transcription factors. CREB1 was able to stimulate HLA-G promoter activity in vitro, and the coactivators CBP and p300 enhanced this effect, revealing thatHLA-G is under the transcriptional control of the CREB/ATF family of proteins. The trophoblast-derived cell lines JEG-3 and JAR, the teratocarcinoma cell line Tera-2, the cervical carcinoma HeLa (American Type Culture Collection, Manassas, VA), the Burkitt lymphoma cell line Raji, and the T leukemia cell line Jurkat were grown in Iscove's modified Dulbecco's medium supplemented with 10% (v/v) heat-inactivated fetal calf serum (Invitrogen), penicillin (100 international units/ml), and streptomycin (100 μg/ml). Luciferase reporter plasmids used were generated by cloning genomic promoter fragments into pGL3-Basic (Promega, Madison, WI). These constructs contain, respectively, a 1438-bp promoter fragment ofHLA-G (pGL3-G1500), a 302-bpβ 2 m PCR-generated promoter fragment (pGL3-β2m), and a 269-bp AspI-AhaIIHLA-B7 promoter fragment (pGL3-HLA-B). The mutant promoter constructs of HLA-G were generated by overlap extension PCR and are based on pGL3-G1500. In the mutant promoter constructs, the putative CRE/TRE site(s) (underlined) were disrupted by introducing aSmaI site or related sequence (bold). The most upstream putative CRE/TRE site (CRE−1380) was flanked by an additional putative CRE/TRE site (both underlined). Therefore, in pGL3-Gm1, both CRE/TRE sites were mutated, changing the CRE−1380 from 5′-GAGAAATGACACACTCTGACTCATAGTAGCAGG-3′ into 5′-GAGAAACCGCCCACTCCCGGGCATAGTAGCAGG-3′. In pGL3-Gm2, the CRE−930 was changed from 5′-GGGGCATTGTGACTGCACTGAACAC-3′ into 5′-GGGGCATTGTCCCGGGGCACTGAACAC-3′, and in pGL3-Gm3, the CRE−770 was changed from 5′-AAACAAGCGGGAGTCACAGATACACT-3′ into 5′-AAACAAGCGCCCGGGACAGATACACT-3′. The mutant pGL3-Gm1–2-3 contained all three mutations in the CRE/TRE sites. All inserts were verified by sequence analysis. The expression vectors Rc/RSV-CREB1 and pECE/RSV-ATF1, Rc/RSV-CBP, and Rc/RSV-p300 and the Renilla luciferase control plasmid pRL-actin were described previously (19Gobin S.J.P. Van Zutphen M. Westerheide S.D. Boss J.M. Van den Elsen P.J. J. Immunol. 2001; 167: 5175-5184Crossref PubMed Scopus (75) Google Scholar). The expression vector pSG5-ICER was a kind gift of Dr. P. Quinn. Adherent cells were transfected by the calcium phosphate co-precipitation method with a DNA precipitate of 1 μg of pGL3 reporter plasmid, 1 or 0.5 μg of expression vector, and 0.1 μg of Renilla luciferase control plasmid (pRL-actin) per well. The cells were harvested 3 days after transfection. Luciferase activity was determined using a luminometer (Tropix, Badford, MA) and corrected for transfection efficiency with the Renilla luciferase activity values. Nuclear extracts were prepared as described before (16Gobin S.J.P. Van Zutphen M. Woltman A.M. Van den Elsen P.J. J. Immunol. 1999; 163: 1428-1434PubMed Google Scholar). Nuclear extracts (about 5 μg of protein) were incubated in DNA/protein binding buffer (20 mm Hepes, pH 7.9, 50 mm KCl, 10% v/v glycerol, 0.5 mmdithiothreitol, 0.1 mm EDTA) with 200 ng of poly(dI·dC), 200 ng of sonicated single stranded herring sperm DNA, and 1 ng of32P-radiolabeled probe for 30 min at 4 °C. The samples were run on a 6% non-denaturing polyacrylamide gel in 0.25× TBE buffer at 200 V for 2 h. The gels were fixed with a 10% methanol and 10% acetic acid solution, dried onto Whatman 3M paper, and exposed to an x-ray film. The following double-stranded oligonucleotides were used as probes and contained the putative CRE/TRE sites of HLA-G: CRE−1380, 5′-GAGAAATGACACACTCTGACTCATAGTAGCAGG-3′; CRE−930, 5′-GGGGCATTGTGACTGCACTGAACAC-3′; and CRE−770, 5′-AAACAAGCGGGAGTCACAGATACACT-3′. In addition, the following double-stranded oligonucleotides were used as probes for the putative ISRE and GAS sites: ISRE−754, 5′-CACTGTCTGGGAAAGTGAAACTTAAGAGCTTTGTGAGTC-3′; GAS−1020, and The double-stranded oligonucleotides used as probes and the assays, 1 μg of against a of the or families of transcription factors was 30 min after the nuclear been incubated with the and this was incubated for an at 4 °C. The used were against CREB1 kind gift of Dr. J. M. CREB/ATF CREB1 CBP and from the CREB1 was prepared from 2 cells as described P. Boss J.M. Immunity. 1999; Full Text Full Text PDF PubMed Scopus (163) Google Scholar). The was with 5 μg of and with and or with protein the samples were by PCR using the for the promoter of HLA-G CRE−1380 The PCR is tissue were prepared after and in by Dr. C. A. Van of and The were at °C. of tissue were at and on were dried at 50 fixed in for and with serum and serum in for 30 the were incubated with against HLA-G by Dr. J. and Dr. A. CREB/ATF 4 and CBP 4 for 30 The and were used as three with the tissue were incubated with to for 30 were three and incubated with 0.5 in 50 mm pH for 5 min to a The were with have shown that the classical regulatory elements found in MHC class I proximal promoter such as enhancer A, the ISRE, and SXY were not in the HLA-G HLA-G conserved regulatory in proximal promoter we searched for putative regulatory elements in the promoter of HLA-G that could for alternative transcriptional control A search in the promoter to the identification of putative ISRE and two putative GAS sites. The two putative GAS sites and not binding after in JEG-3 nuclear whereas binding to a binding site was not In the putative ISRE site binding of IRF1 using nuclear extracts from JEG-3 binding of and was This IRF1 binding to the of this site to mediate transactivation of HLA-G. However, in transient transfection assays, has been of promoter activity in JEG-3 cells 1 induction of HLA-G promoter activity by and was in JEG-3 cells 1 a of induction by was in trophoblast-derived cell lines (18Gobin S.J.P. Van den Elsen P.J. Hum. Immunol. 2000; 61: 1102-1107Crossref PubMed Scopus (112) Google Scholar). this could be the of the induction of HLA-G in JEG-3 we responses in in which classical MHC class I genes are by (16Gobin S.J.P. Van Zutphen M. Woltman A.M. Van den Elsen P.J. J. Immunol. 1999; 163: 1428-1434PubMed Google Scholar). However, in this cell the promoter activity of HLA-G by or was not at 1 despite a induction of and 2 activity by This that ISRE and GAS not a role in A search the presence of three CRE/TRE sites CRE−1380, CRE−930, and in the promoter of HLA-G. The most upstream of the three (CRE−1380) was flanked by a CRE/TRE this CRE/TRE site (CRE−1380) was in the shown previously to be important for the expression of M.C. J. Immunol. Google Scholar). We the three CRE/TRE sites CRE−930, and for binding activity of proteins of the CREB/ATF and Fos/Jun families of transcription factors in vitro. The most upstream CRE/TRE site (CRE−1380) binding of and The CRE/TRE site predominantly binding of a complex that contained predominantly whereas the CRE/TRE site binding of CREB1 and This implies that the CRE/TRE sites bind which could be and and that CREB1 was the factor in the binding to sites. the in vivo binding of CREB/ATF and Fos/Jun we a this of JEG-3 DNA with CREB, or the in vivo binding of and to the upstream of the HLA-G promoter CRE−1380 in JEG-3 cells However, this binding not to be in vivo CREB binding to promoter was in and cells not The of CRE/TRE sites to HLA-G transactivation was in a reporter gene using a the 1438-bp promoter of HLA-G. Both CREB1 and could promoter activity However, of CREB1 with could not transactivation 4 promoter activity was not by CREB1 in JEG-3 cells not of CREB1 with the coactivators CBP and p300 enhanced transactivation of HLA-G 4 could stimulate promoter activity ofHLA-G not CREB1 could promoter activity in that for this transcription factors are not The role of CREB in the transactivation of HLA-G was investigated by the of which can transcription C.A. P. Full Text PDF PubMed Scopus Google Scholar). In transient the transactivation of 4 was able to the promoter activity of of not the importance of the CRE/TRE sites in the transactivation of HLA-G, we mutations in the CRE/TRE sites CRE−1380, CRE−930, and transfection of constructs, a in the CRE/TRE sites pGL3-Gm2, and or in all three CRE/TRE sites that in of the three sites in a of whereas of all three sites the of CREB to the transactivation of 4 the of HLA-Gtransactivation of the constructs were to a the for the HLA-G with CRE−1380 4 This that the of CRE−1380 was most important by CRE−930 and were in cell that the importance of the three CRE/TRE sites for the of promoter activity was not Together, this that the three CRE/TRE sites in the promoter of important for the transactivation The promoter binding and regulation ofHLA-G by CREB in the cell line JEG-3 of HLA-G with transcription factors in tissue. the relevance of this transactivation we for the in of CREB, and HLA-G by immunohistochemical analysis. In the extravillous cytotrophoblast cells were identified on the of their and their for not These extravillous for HLA-G, particularly on the cell This expression of HLA-G in the cells with the predominantly nuclear of CREB/ATF and CBP and The in of CREB/ATF and CBP that transcription factors could their role in HLA-Gtransactivation in have shown that HLA-G is found in extravillous and few The limited tissue suggests that HLA-G has (3Le Bouteiller P. Solier C. Microbes Infect. 2001; 3: 323-332Crossref PubMed Scopus (32) Google Scholar, 11Carosella E.D. Dausset J. Kirszenbaum M. Immunol. Today. 1996; 17: 407-409Abstract Full Text PDF PubMed Scopus (113) Google Scholar, Bouteiller P. Solier C. J. Aguerre-Girr M. S. Lenfant F. Hum. Reprod. 1999; PubMed Scopus Google Scholar). Among the MHC class I molecules, the regulation HLA-G is not HLA-G is not regulated by the transactivation pathways that the expression of the classical MHC class I molecules regulatory elements that are to the transcription of the classical class I molecules, such as enhancer A, the ISRE, and the SXY in S.J.P. Van den Elsen P.J. Hum. Immunol. 2000; 61: 1102-1107Crossref PubMed Scopus (112) Google Scholar). The two putative κB sites of enhancer A of been shown to bind predominantly the of using nuclear of cells (15Gobin S.J.P. Keijsers V. Van Zutphen M. Van den Elsen P.J. J. Immunol. 1998; 161: 2276-2283PubMed Google Scholar). However, in there is and it is by J. P. J. M. P. and P. J. Van den not transactivation properties, which the lack of response to and the lack of activation by in reporter gene In addition, the most upstream of the two κB sites has been found to bind (15Gobin S.J.P. Keijsers V. Van Zutphen M. Van den Elsen P.J. J. Immunol. 1998; 161: 2276-2283PubMed Google Scholar). The and ISRE is and has binding affinity for IRF1, or (16Gobin S.J.P. Van Zutphen M. Woltman A.M. Van den Elsen P.J. J. Immunol. 1999; 163: 1428-1434PubMed Google Scholar). However, a probe this ISRE was able to bind is that sites could to the of HLA-G The SXY module ofHLA-G is from the of the and Although have a binding of to the of HLA-G P. P. M. Dausset J. Carosella E.D. P. Hum. Immunol. 2000; 61: PubMed Scopus Google Scholar), to binding of protein to the SXY module with complex not binding of the such as that for classical MHC class I genes (19Gobin S.J.P. Van Zutphen M. Westerheide S.D. Boss J.M. Van den Elsen P.J. J. Immunol. 2001; 167: 5175-5184Crossref PubMed Scopus (75) Google binding of CREB/ATF to the or binding to the of HLA-G was not in to the binding of CREB/ATF and to the and of (19Gobin S.J.P. Van Zutphen M. Westerheide S.D. Boss J.M. Van den Elsen P.J. J. Immunol. 2001; 167: 5175-5184Crossref PubMed Scopus (75) Google This the lack of induction of HLA-G by (14Van den Elsen P.J. Gobin S.J. van Eggermond M.C. Peijnenburg A. Immunogenetics. 1998; 48: 208-221Crossref PubMed Scopus (123) Google Scholar, S.J.P. Van den Elsen P.J. Hum. Immunol. 2000; 61: 1102-1107Crossref PubMed Scopus (112) Google Scholar). is still as to HLA-G is responsive to have that HLA-G is by and S. S. F. P. S. Dausset J. Carosella E.D. P. J. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). In this study, we identified putative ISRE and two putative GAS sites. the putative ISRE site binding of IRF1 using nuclear extracts from JEG-3 However, binding was to the two putative GAS sites and which is in line with by J. Immunol. 1999; PubMed Scopus Google Scholar). The binding of IRF1 to the the that could transactivation of HLA-G. However, in transient transfection assays, was of promoter activity in JEG-3 induction of HLA-G promoter activity by and was in JEG-3 in the promoter activity of HLA-G was by or IFNγ, which was in to the induction of the promoter activity of 2 m by We that the promoter of HLA-G is not responsive to by In search for alternative regulatory pathways that control the transcription of HLA-G, we identified three CRE/TRE elements in the promoter of HLA-G the trophoblast-derived cell line the sites and in vitro. The binding of proteins of the CREB/ATF and Fos/Jun families of proteins the of However, the of the protein binding to the promoter is not and the of transcription factors be in assays, CREB1 and were found to the upstream promoter in vivo. this has been with the expression of HLA-G in and was shown to display protein binding activity M.C. J. Immunol. Google Scholar, P. P. S. Dausset J. Carosella Kirszenbaum M. Hum. Immunol. PubMed Scopus Google Scholar). that HLA-G transactivation is regulated by CREB CREB promoter activity and promoter activity in reporter In addition, the activation by CREB was enhanced by of the coactivators analysis the importance of all three CRE/TRE sites in the regulation ofHLA-G transcription by CREB and the of promoter activity of HLA-G. CREB1 could activity in cell that for this transcription factors are However, promoter activity was not by CREB1 in JEG-3 a differential regulation of HLA-G classical MHC class I in CREB is to be an important factor for the expression of genes in trophoblasts and the of is regulated by sites including J. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar, M. R. P. 2000; PubMed Scopus Google Scholar, 11: Google Scholar). However, the expression of the of was by an additional regulatory element the expression that is not found in the HLA-G Moreover, CREB/ATF proteins are ubiquitously expressed transcription and analysis the binding of CREB to promoter in cell lines not HLA-G. Therefore, they are not to for it be that a trophoblasts and cells in the of the CREB/ATF complex binding the sites to the expression 1994; PubMed Scopus Google Scholar, P. PubMed Scopus Google Scholar). Therefore, it to be determined a regulatory site or transcription is for the expression of HLA-G. could be that general a role in the expression or of HLA-G, such as promoter with expression of HLA-G in cell lines HLA-G expression as by whereas in cell induction of HLA-G expression was J. P. P. and P. J. Van den However, in vitro promoter of the reporter in a of promoter activity and of Moreover, in cell lines HLA-G expression of the HLA-G promoter was suggests it promoter is not the a expression of HLA-G M. M. A.M. P. R. Le Bouteiller P. Am. J. Reprod. Immunol. PubMed Scopus Google Scholar). general that could a role in the expression of HLA-G is the of the HLA-G promoter contains two κB sites in enhancer A, which display binding affinity for (15Gobin S.J.P. Keijsers V. Van Zutphen M. Van den Elsen P.J. J. Immunol. 1998; 161: 2276-2283PubMed Google Scholar). the of not activity and factors are present in most cell not in the functional relevance of this binding in cells has However, a has attributed a role for to transcriptional of J. S. 9: Full Text Full Text PDF PubMed Scopus Google Scholar). could be that in binding to the κB sites of HLA-G which represses HLA-G transcription and as such to the expression of HLA-G. CRE/TRE sites in the promoter of HLA-G mediate regulation by CREB/ATF factors. This is the of a regulatory the 1438-bp promoter of HLA-G. We Dr. J. Dr. A. Dr. C. A. Van and Dr. P. for and tissue We Dr. N. Van for the

References

26